Sobi
The US Regulatory Strategy Lead is responsible for shaping and implementing US regulatory strategies for development and marketed products at Sobi. They serve as a key member of the Global Regulatory Team, providing expertise on US regulations, facilitating interactions with regulatory agencies, and supporting product development and approval processes.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
57% above the average for this role
Director, US Product Group Regulatory Affairs
Digital Biology
Associate Director, Regulatory Affairs CMC (Biologics, Combination Products)
1080030P
Director or Senior Associate Director, US Product Group Regulatory Affairs
Digital Biology
Regulatory Affairs Principal, Pharmaceutical and Combination Products
Meridian Bioscience, Inc.
Regulatory Affairs Director
AstraZeneca
Vice President, US Regulatory Affairs
ITF Therapeutics